Now boarding for stem cell therapy offshore

Summary: Patients from around the world are discovering that they can live less restricted lives, free from many of the disabling symptoms associated with progressive diseases once considered untreatable. Traveling overseas for adult stem cell therapy is now mainstream medicine.

BANGKOK, Thailand, 13 December 2007 – Global regenerative medicine consultants Jai Communications Associates have recently noted a surge of inquiries from patients seeking stem cell treatments abroad.

“It is clear that the message is getting out to the world,” said Director Brian Dardzinski. “People are aware of the fact that instead of putting up with disabling and restrictive symptoms from diseases without hope of a cure that help is available right now,” he added.

Adult stem cell treatments are not new. For many years leukemia has been treated effectively with stem cells. More recently breakthroughs have been coming at an increasing pace, backed up by clinical studies and patient reports. In various parts of the world patients are getting considerable relief from conditions such as spinal cord injury, multiple sclerosis, diabetes, autism, peripheral artery disease, ALS, cartilage problems, retinitis pigmentosa and many others.

“It is important for people to know that these stem cell treatments are considered experimental by many Western nations. It is early days yet, so government-regulated bodies like the FDA are lagging well behind in approving large scale clinical studies in countries such as the USA. The explosive growth is coming from the fact that around 75-80 percent of patients are receiving significant help. They don’t have years to wait for government approval. Regenerative medicine is currently being driven by patient outcomes,” Brian said.

Independent websites such as www.StemCells21.com are simply health brokers. They obtain the medical history from patients and assuming the patients are ready to travel and able to pay they find the best treatment provider for that patient. “It’s a privilege to be able to help people who thought they were beyond help. The future is incredibly exciting because almost daily new clinical trial results are being published. It is our job to know exactly who is doing what and where and with what success. In this way we can guide patients with integrity and compassion and make a real difference in their lives,” Mr. Dardzinski added.

Jai Communications Associates

www.stemcellguidance.com